Who We Are

Our team is comprised of industry leaders with decades of experience in early stage biotechnology startups, translational drug development, and practice-changing Phase III clinical trials.

Meet the Team

What We’re Doing

Toragen is focused on repurposing anti-viral drugs and developing novel immunotherapies to treat viral-associated cancers.

Learn More

Where We’re Going

Toragen is preparing to initiate a Phase I clinical trial with its lead compound in HPV-associated malignancies and is seeking investor funding for research and development.

See What’s in Store